CorMedix Inc.
CRMD
$11.50
$1.4314.20%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 121.48M | 82.55M | 43.47M | 12.26M | 806.10K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 121.48M | 82.55M | 43.47M | 12.26M | 806.10K |
| Cost of Revenue | 5.32M | 3.97M | 3.19M | 2.01M | 1.33M |
| Gross Profit | 116.16M | 78.59M | 40.28M | 10.25M | -522.20K |
| SG&A Expenses | 58.76M | 57.81M | 58.70M | 56.70M | 51.18M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 72.17M | 68.08M | 65.83M | 63.22M | 58.95M |
| Operating Income | 49.32M | 14.47M | -22.36M | -50.96M | -58.14M |
| Income Before Tax | 51.68M | 17.18M | -19.32M | -47.54M | -54.51M |
| Income Tax Expenses | 521.50K | 0.00 | -1.39M | -1.39M | -1.39M |
| Earnings from Continuing Operations | 51.16 | 17.18 | -17.93 | -46.15 | -53.12 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 51.16M | 17.18M | -17.93M | -46.15M | -53.12M |
| EBIT | 49.32M | 14.47M | -22.36M | -50.96M | -58.14M |
| EBITDA | 49.85M | 14.92M | -22.05M | -50.77M | -58.01M |
| EPS Basic | 0.78 | 0.24 | -0.33 | -0.80 | -0.93 |
| Normalized Basic EPS | 0.49 | 0.15 | -0.22 | -0.52 | -0.59 |
| EPS Diluted | 0.75 | 0.22 | -0.33 | -0.81 | -0.93 |
| Normalized Diluted EPS | 0.47 | 0.14 | -0.22 | -0.52 | -0.59 |
| Average Basic Shares Outstanding | 253.51M | 243.20M | 235.46M | 231.34M | 229.07M |
| Average Diluted Shares Outstanding | 261.23M | 246.93M | 235.46M | 231.34M | 229.07M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |